TuranTAkyuzARAykanAC. Plasma endocan levels in patients with isolated coronary artery ectasia. Angiology. 2016;pii:0003319716637789.
2.
FalsettiHLCarrolRJ. Coronary artery aneurysm. A review of the literature with a report of 11 new cases. Chest. 1976;69(5):630–636.
3.
KoseMEmetSAkpinarTS. Serum endocan level and the severity of coronary artery disease: a pilotstudy. Angiology. 2015;66(8):727–731.
4.
BaltaSMikhailidisDPDemirkolS. Endocan: a novel inflammatory indicator in cardiovascular disease?Atherosclerosis. 2015;243(1):339–343.
5.
SyedDIqbalOMosierM. Elevated endocan levels and its association with clinical severity in Stevens-Johnson syndrome and toxic epidermal necrolysis. Int Angiol. 2015;34(5):483–488.
6.
IcliACureECureMC. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology. 2016;67(8):749–755.
7.
KøstnerAHKerstenCLöwenmarkT. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker. J Surg Oncol. 2016;114(7):895–899.
8.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411.
9.
AtisOKelesMCankayaE. Vitamin D treatment effect on serum endocan and high-sensitivity C-reactive protein levels in renal transplant patients. Prog Transplant. 2016;pii:1526924816664086.
